Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Demethylating Agents Reprogram Myelodysplastic Syndrome and Leukemia Cells, Sensitizing Them To Poly-(ADP)-Ribose Polymerase Inhibitors

Carine Robert, PhD, Nidal E Muvarak, MS, Vu H. Duong, MD, Maria R. Baer, MD, Stephen B. Baylin, MD, Feyruz Rassool, PhD

Blood (2013) 122 (21): 3778.

https://doi.org/10.1182/blood.V122.21.3778.3778

Published: 2013

Journal Articles

Dimeric Naphthoquinones: Novel Anti-Leukemic Agents Modulating Cellular Redox Status

Ashkan Emadi, M.D., Ph.D., Mariola Sadowska, PhD, Brandon Carter-Cooper, BS, Omasiri Wonodi, BS, Nidal Muvarak, BS, Feyruz Rassool, PhD, Anil Jaiswal, PhD, Maria R. Baer, MD, Rena G. Lapidus, PhD, Edward A. Sausville, MD, PhD

Blood (2013) 122 (21): 1290.

https://doi.org/10.1182/blood.V122.21.1290.1290

Published: 2013

Journal Articles

C-MYC and C-MYC-Regulated Micrornas Increase The Activity Of The Error-Prone ALT NHEJ Pathway Through Upregulation Of LIG3 and PARP1 In Tyrosine Kinase-Activated Leukemias

Nidal E. Muvarak, MS, Shannon M. Kelley, BS, Mario Tarasco, Maria R. Baer, MD, Kara A. Scheibner, PhD, Feyruz Rassool, PhD

Blood (2013) 122 (21): 809.

https://doi.org/10.1182/blood.V122.21.809.809

Published: 2013

Journal Articles

Increased Mutation Frequency Induced by Oxidative Stress in the NUP98-HOXD13 MDS Mouse Model

Yang Jo Chung, PhD, Carine Robert, PhD, Sheryl M Gough, BSc, PhD, Feyruz Rassool, PhD, Peter Aplan, MD

Blood (2011) 118 (21): 1705.

https://doi.org/10.1182/blood.V118.21.1705.1705

Published: 2011

Journal Articles

The Dark Side of NRF2: Upregulation of NRF2 as a Mechanism for Resistance to Imatinib In CML.

Dipika Gemani, MS, Lisa A Tobin, Anju Singh, MD, MPH, Maria R Baer, MD, Shyam Biswal, PhD, MS, Feyruz Rassool, PhD

Blood (2010) 116 (21): 3401.

https://doi.org/10.1182/blood.V116.21.3401.3401

Published: 2010

NARROW

Demethylating Agents Reprogram Myelodysplastic Syndrome and Leukemia Cells, Sensitizing Them To Poly-(ADP)-Ribose Polymerase Inhibitors

Dimeric Naphthoquinones: Novel Anti-Leukemic Agents Modulating Cellular Redox Status

C-MYC and C-MYC-Regulated Micrornas Increase The Activity Of The Error-Prone ALT NHEJ Pathway Through Upregulation Of LIG3 and PARP1 In Tyrosine Kinase-Activated Leukemias

Increased Mutation Frequency Induced by Oxidative Stress in the NUP98-HOXD13 MDS Mouse Model

The Dark Side of NRF2: Upregulation of NRF2 as a Mechanism for Resistance to Imatinib In CML.

Email alerts

ASH Publications

American Society of Hematology

Demethylating Agents Reprogram Myelodysplastic Syndrome and Leukemia Cells, Sensitizing Them To Poly-(ADP)-Ribose Polymerase Inhibitors

Dimeric Naphthoquinones: Novel Anti-Leukemic Agents Modulating Cellular Redox Status

C-MYC and C-MYC-Regulated Micrornas Increase The Activity Of The Error-Prone ALT NHEJ Pathway Through Upregulation Of LIG3 and PARP1 In Tyrosine Kinase-Activated Leukemias

Increased Mutation Frequency Induced by Oxidative Stress in the NUP98-HOXD13 MDS Mouse Model

The Dark Side of NRF2: Upregulation of NRF2 as a Mechanism for Resistance to Imatinib In CML.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only